Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Cash from Investing Activities (2020 - 2022)

MediXall's Cash from Investing Activities history spans 3 years, with the latest figure at -$1379.0 for Q4 2022.

  • For Q4 2022, Cash from Investing Activities fell 264.17% year-over-year to -$1379.0; the TTM value through Dec 2022 reached -$1379.0, up 89.26%, while the annual FY2022 figure was -$1379.0, 89.26% up from the prior year.
  • Cash from Investing Activities reached -$1379.0 in Q4 2022 per MDXL's latest filing, down from $1680.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1680.0 in Q3 2022 to a low of -$52605.0 in Q3 2020.
  • Average Cash from Investing Activities over 3 years is -$9845.5, with a median of -$1529.5 recorded in 2022.
  • The largest YoY upside for Cash from Investing Activities was 300.0% in 2022 against a maximum downside of 264.17% in 2022.
  • A 3-year view of Cash from Investing Activities shows it stood at -$11940.0 in 2020, then soared by 107.04% to $840.0 in 2021, then tumbled by 264.17% to -$1379.0 in 2022.
  • Per Business Quant, the three most recent readings for MDXL's Cash from Investing Activities are -$1379.0 (Q4 2022), $1680.0 (Q3 2022), and -$1680.0 (Q1 2022).